Japanese Antivirals Shown Effective Against H1N1 In Animal Trial
This article was originally published in PharmAsia News
Executive Summary
A pair of antivirals being developed by Japanese drug makers have shown to be effective against the H1N1 virus, according to scientists in a published study. The University of Tokyo, and the University of Wisconsin in the United States conducted studies on drugs still under development by Daiichi Sankyo and Toyama Chemical. Daiichi Sankyo's CS-8958 and Toyama's T-705, each in clinical trials, were tested on animals and found to lower virus levels by a considerable amount. Toyama's drug works by inhibiting the RNA polymerase protein while Daiichi Sankyo's is similar to the two major flu antivirals. (Click here for more - a subscription may be required
|
A pair of antivirals being developed by Japanese drug makers have shown to be effective against the H1N1 virus, according to scientists in a published study. The University of Tokyo, and the University of Wisconsin in the United States conducted studies on drugs still under development by Daiichi Sankyo and Toyama Chemical. Daiichi Sankyo's CS-8958 and Toyama's T-705 , each in clinical trials, were tested on animals and found to lower virus levels by a considerable amount. Toyama's drug works by inhibiting the RNA polymerase protein while Daiichi Sankyo's is similar to the two major flu antivirals. (Click here for more - a subscription may be required) "2 New Antivirals Effective Against Swing Flu" - Nikkei (Japan) (7/15/09) |